Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mehmet Dokmeci

Associate Professor

Terasaki Institute for Biomedical Innovation

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Tissue Engineering Tissue Engineering professors in United States

About

Mehmet Dokmeci is an Associate Professor at the Terasaki Institute for Biomedical Innovation in the United States. His research focuses on advanced biomedical technologies including microneedling for skin cancer treatment, biological nanocarriers in cancer therapy, and innovative drug delivery systems. He is actively engaged in developing 3D bioprinting techniques and microphysiological systems for tissue engineering and drug resistance studies in glioblastoma.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (5)

Ankit Gangrade

Research Associate

University of Colorado Boulder

UNITED STATES

View details

lino ferreira

Coordinator Researcher (equiv. to Full Professor)

Universidade do Porto Faculdade de Medicina

PORTUGAL

View details

Surjendu Maity

Assistant professor

Indian Institute of Technology, Kharagpur

View details

Danilo Demarchi

Docenti di ruolo di Ia fascia

Politecnico di Torino

ITALY

View details

Ali Khademhosseini

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mehmet Dokmeci

Research Interests

Make your next move.

Explore related searches

About

Articles (15)

A human skin-on-a-chip platform for microneedling-driven skin cancer treatment

Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery

Correction to: A Bioactive Carbon Nanotube-Based Ink for Printing 2D and 3D Flexible Electronics (Advanced Materials, (2016), 28, 17, (3280-3289), 10.1002/adma.201506420)

Correction to: A Patch of Detachable Hybrid Microneedle Depot for Localized Delivery of Mesenchymal Stem Cells in Regeneration Therapy (Advanced Functional Materials, (2020), 30, 23, 10.1002/adfm.202000086)

Correction to: A Textile Dressing for Temporal and Dosage Controlled Drug Delivery (Advanced Functional Materials, (2017), 27, 41, 10.1002/adfm.201702399)

Correction to: Microfluidics-Enabled Multimaterial Maskless Stereolithographic Bioprinting (Advanced Materials, (2018), 30, 27, 10.1002/adma.201800242)

Corrigendum to ‘Bioprinting 3D microfibrous scaffolds for engineering cardiac tissues and heart-on-a-chip’ [Biomaterials Volume 110, (2016) Pages 45–59, (S014296121630477X), (10.1016/j.biomaterials.2016.09.003)]

Corrigendum to ‘Direct 3D bioprinting of perfusable vascular constructs using a blend bioink’ [Biomaterials Volume 106, (2016) Pages 58–68, (S0142961216303751), (10.1016/j.biomaterials.2016.07.038)]

Corrigendum to “Oxygen-generating microparticles downregulate HIF-1α expression, increase cardiac contractility, and mitigate ischemic injury” [Acta Biomaterialia, 2023, 159, 211-225] (Acta Biomaterialia (2023) 159 (211–225), (S1742706123000296), (10.1016/j.actbio.2023.01.030))

Deciphering pericyte-induced temozolomide resistance in glioblastoma with a 3D microphysiological system mimicking the biomechanical properties of brain tissue

Real-time and label-free monitoring of monoclonal antibody secretion rates using a PC-TIR biosensor

Development of silk microfiber-reinforced bioink for muscle tissue engineering and in situ printing by a handheld 3D printer

Recent Developments in Glioblastoma-On-A-Chip for Advanced Drug Screening Applications

Smart biomaterials in healthcare: Breakthroughs in tissue engineering, immunomodulation, patient-specific therapies, and biosensor applications

Development and Quantitative Evaluation of a Novel Autonomous In Situ Bioprinting Surgical Robotic Framework for Treatment of Volumetric Muscle Loss Injuries

Collaborators (5)

Ankit Gangrade

lino ferreira

Surjendu Maity

Danilo Demarchi

Ali Khademhosseini

Make your next move.